SEC Form 4Coverage since May 21, 2026
$SER insider trading
Over the last 12 months, Serina Therapeutics insiders reported 4 buys totaling $39K and no sales across SEC Form 4 filings.
- Bought · 12m
- $39K 4 events
- Sold · 12m
- — 0 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $SER · 12Mvia TradingView
Top insiders · 12m
WILSON KAREN J—2× · $35K
Brannan Stephen K.—1× · $2K
Venkatesan Jay—1× · $1K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Brannan Stephen K.D | ▲ Buy | 1,000 | $2.03 | $2K | — | — |
| Jun 12, 2026 | WILSON KAREN JD | ▲ Buy | 10,100 | $1.76 | $18K | — | 2 tranches |
| May 22, 2026 | Venkatesan JayD | ▲ Buy | 589 | $1.78 | $1K | — | late |
| May 21, 2026 | WILSON KAREN JD | ▲ Buy | 10,000 | $1.77 | $18K | — | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SER feed.